These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26791072)

  • 1. Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    Giral P; Hansel B; Chapman J
    J Am Coll Cardiol; 2016 Jan; 67(2):234. PubMed ID: 26791072
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    Tsujita K; Sugiyama S; Shimomura H; Yamanaga K; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2016 Jan; 67(2):234-235. PubMed ID: 26791071
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe and Plaque Regression: Cholesterol Lowering or Pleiotropic Effects?
    Crea F; Niccoli G
    J Am Coll Cardiol; 2015 Aug; 66(5):508-10. PubMed ID: 26227187
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating Statin Versus Statin Plus Ezetimibe for Coronary Plaque Regression.
    Mascitelli L; Goldstein MR
    J Am Coll Cardiol; 2015 Dec; 66(25):2916. PubMed ID: 26718684
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply: Evaluating Statin Versus Statin Plus Ezetimibe for Coronary Plaque Regression.
    Tsujita K; Sugiyama S; Shimomura H; Yamanaga K; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Dec; 66(25):2916-2917. PubMed ID: 26718685
    [No Abstract]   [Full Text] [Related]  

  • 7. Intriguing Off-Target Effects of Ezetimibe.
    Koh KK
    J Am Coll Cardiol; 2015 Dec; 66(24):2808. PubMed ID: 26700841
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply: Intriguing Off-Target Effects of Ezetimibe.
    Tsujita K; Sugiyama S; Shimomura H; Yamanaga K; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Dec; 66(24):2808-2809. PubMed ID: 26700842
    [No Abstract]   [Full Text] [Related]  

  • 9. Getting What the Guidelines Stated Matters.
    Stone NJ; Lloyd-Jones D; Smith S
    J Am Coll Cardiol; 2016 Jan; 67(1):119-20. PubMed ID: 26764076
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply: Getting What the Guidelines Stated Matters.
    Tsujita K; Sugiyama S; Shimomura H; Yamanaga K; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2016 Jan; 67(1):120-1. PubMed ID: 26764077
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.
    Montone RA; Testa L; Bedogni F
    J Am Coll Cardiol; 2016 Jan; 67(2):235-236. PubMed ID: 26791073
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.
    Abdel-Wahab M; Richardt G
    J Am Coll Cardiol; 2016 Jan; 67(2):236-237. PubMed ID: 26791074
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-density lipoprotein cholesterol lowering therapy and established atherosclerosis.
    Kawaguchi R
    Circ J; 2012; 76(1):49-50. PubMed ID: 22122970
    [No Abstract]   [Full Text] [Related]  

  • 14. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study.
    Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
    J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
    Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
    J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent.
    Azar M; Valentin E; Badaoui G; Kassab R; Sarkis A; Azar RR
    Am J Cardiol; 2011 Jun; 107(11):1571-4. PubMed ID: 21439529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
    Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
    Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.
    Azar RR; Badaoui G; Sarkis A; Azar M; Aydanian H; Harb S; Achkouty G; Kassab R
    Am J Cardiol; 2010 Jul; 106(2):193-7. PubMed ID: 20599002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.